Crossing the River Styx: The myth of multichannel
A word from Aurora, goddess of the dawn I like to think of multichannel in terms of Greek mythology; it is the mythical beast that must be tamed or slayed,…
Archive: 2013
-
-
It’s not all doom and gloom: A look back at the NHS in 2013
It’s been a turbulent year for the NHS. They’ve taken some hammering in the media throughout 2013, starting with the publication of the Francis report following the Mid-Staffs scandal, detailing…
-
Aurora top 20, November 2013 news analysis
With this month’s devastating news regarding Typhoon Haiyan and its destructive path through south-east Asia, it was heart-warming to see the world rush to help those countries worst affected. In the…
-
Value-based medicine pricing: pay day cannot come too soon
This blog post was originally posted on the GLOBALHealthPR blog on 25 November 2013 by this author. When does your employer pay you for your toil? For the Brits reading…
-
Aurora top 20, October 2013 news analysis
Well, October is now well and truly behind us, and what a stormy October it has been, both on the weather front and in the health news! St Jude was…
-
NHS Top 20, September 2013 news analysis
Most of us may only just be coming to terms with autumn but for the NHS one eye is firmly locked on what winter will bring this year, and the…
-
Aurora top 20, September 2013 news analysis
Autumn has definitely arrived as we look back at the news highlights from September. It seems the coming winds are mixing things up in the top 20, and as several…
-
Aurora top 20, August 2013 news analysis
With August just behind us we’ve finally said goodbye to the last official month of summer which seems to have gone by in record time. Although the seasons come and…
-
The tale of the press release
Once upon a time there was a hare who, boasting how he could run faster than anyone else, was forever teasing tortoise for his slowness. Then one day, the irate…
-
The wonders of e-learning
Is e-learning the way forward for health care professionals and how can pharma get involved? We take a look at the options and advantages. In the last newsletter we raised…
